Chairman and Executive Director Cai Dongchen increases holdings in CSPC PHARMA (01093) by 6.706 million shares at a price of HK$8.85 per share.
On December 23, Chairman and Executive Director Cai Dongchen increased his holdings of Sino Pharmaceutical Group (01093) by 6.706 million shares, with a price of 8.85 Hong Kong dollars per share, for a total amount of approximately 593.481 million Hong Kong dollars.
The latest information from the Hong Kong Stock Exchange shows that on December 23rd, Chairman and Executive Director Cai Dongchen increased his holdings of CSPC PHARMA (01093) by 6.706 million shares, with a price of 8.85 Hong Kong dollars per share, for a total amount of approximately 59.3481 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 2.917 billion shares, with a latest shareholding percentage of 25.31%.
Related Articles
Jiangsu Chengxing Phosph-Chemicals (600078.SH): The Jiangyin factory will officially cease production fully starting from January 24, 2026.
Shareholder Park Huahui of Hicon Network Technology (301262.SZ) plans to reduce his holdings by no more than 3.60%.
HuaDian Heavy Industries (601226.SH) was awarded the first prize of the 2025 Power Innovation Award.
Jiangsu Chengxing Phosph-Chemicals (600078.SH): The Jiangyin factory will officially cease production fully starting from January 24, 2026.
Shareholder Park Huahui of Hicon Network Technology (301262.SZ) plans to reduce his holdings by no more than 3.60%.
HuaDian Heavy Industries (601226.SH) was awarded the first prize of the 2025 Power Innovation Award.
RECOMMEND
